Detalles de la búsqueda
1.
Severe Bacterial Non-AIDS Infections in Persons With Human Immunodeficiency Virus: The Epidemiology and Evolution of Antibiotic Resistance Over an 18-Year Period (2000-2017) in the ANRS CO3 AquiVih-Nouvelle-Aquitaine Cohort.
Clin Infect Dis
; 76(10): 1814-1821, 2023 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36610063
2.
Time to Treatment Initiation and HIV Viral Suppression in People Diagnosed With HIV-1 During COVID-19 Pandemic in Ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study).
J Acquir Immune Defic Syndr
; 95(1): 1-5, 2024 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37757852
3.
Long-term follow-up of HIV-1 multi-drug-resistant treatment-experienced participants treated with etravirine, raltegravir and boosted darunavir: towards drug-reduced regimen? ANRS CO3 Aquitaine Cohort 2007-2018.
Int J Antimicrob Agents
; 61(1): 106696, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36470511
4.
Statin use and risk of severe bacterial infection in a population living with HIV: prospective cohort study of the ANRS CO3 Aquitaine Cohort 2000-2018.
Clin Microbiol Infect
; 27(9): 1301-1307, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33276140
5.
Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study).
Antivir Ther
; 20(6): 655-60, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25735799
Resultados
1 -
5
de 5
1
Próxima >
>>